SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BREVEGLIERI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.560
EU - Europa 2.888
AS - Asia 1.817
SA - Sud America 20
OC - Oceania 12
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.309
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.525
CN - Cina 1.023
PL - Polonia 815
IT - Italia 653
UA - Ucraina 404
SG - Singapore 372
DE - Germania 339
TR - Turchia 234
GB - Regno Unito 200
SE - Svezia 164
FI - Finlandia 113
FR - Francia 82
ID - Indonesia 66
BE - Belgio 33
CA - Canada 31
IR - Iran 27
IN - India 22
VN - Vietnam 19
CZ - Repubblica Ceca 15
NL - Olanda 15
BR - Brasile 14
RU - Federazione Russa 14
HK - Hong Kong 13
KR - Corea 11
AU - Australia 10
RO - Romania 9
LT - Lituania 7
MY - Malesia 7
JP - Giappone 6
TW - Taiwan 6
CH - Svizzera 5
ES - Italia 5
TN - Tunisia 5
EG - Egitto 4
AR - Argentina 3
GR - Grecia 3
PT - Portogallo 3
IE - Irlanda 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
TH - Thailandia 1
Totale 11.309
Salva come PNG Salva come JPEG
Città #
Warsaw 808
Woodbridge 698
Fairfield 558
Chandler 557
Ann Arbor 492
Jacksonville 485
Houston 477
Ashburn 427
Santa Clara 384
Beijing 344
Singapore 303
Wilmington 274
Ferrara 238
Seattle 226
Nanjing 183
Cambridge 166
Izmir 145
Princeton 116
Bologna 101
Boardman 89
Addison 84
New York 76
Milan 72
Shanghai 71
Jakarta 58
Bremen 55
Shenyang 53
San Diego 50
Redwood City 48
Nanchang 46
Los Angeles 37
Falls Church 36
Hebei 35
Dearborn 31
Brussels 29
Changsha 27
Zhengzhou 25
Auburn Hills 24
Jiaxing 23
San Jose 23
London 22
Mountain View 21
Tianjin 21
Dong Ket 19
Guangzhou 19
Munich 19
Toronto 19
Norwalk 16
Jinan 15
Ningbo 14
Orange 14
Brno 13
Ferrara di Monte Baldo 13
Helsinki 13
Kunming 13
Hefei 11
Indiana 10
Napoli 10
Verona 10
Des Moines 9
Hangzhou 9
Leawood 9
Lanzhou 8
Washington 8
Leiden 7
Frankfurt am Main 6
Fuzhou 6
Hong Kong 6
Kraków 6
San Mateo 6
Sydney 6
Taizhou 6
Yogyakarta 6
Cattolica 5
Lappeenranta 5
Paris 5
Pars 5
Rome 5
San Francisco 5
Taipei 5
Chengdu 4
Philadelphia 4
Pune 4
Ravenna 4
Wuhan 4
Ardabil 3
Bournemouth 3
Buenos Aires 3
Changchun 3
Falkenstein 3
Florence 3
Gent 3
Kilburn 3
Kota Bharu 3
Kundan 3
Modena 3
Moscow 3
North Bergen 3
Ottawa 3
Padova 3
Totale 8.464
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 313
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 287
A validated cellular biobank for β-thalassemia 284
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 234
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 212
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 205
A validated THALAMOSS cellular biobank for β-thalassemia 197
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 180
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 175
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 171
SPR-based non-invasive prenatal testing for fetal sex determination 155
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 153
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 152
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 144
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 143
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 143
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 135
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 129
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 128
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 127
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 125
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 120
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 119
null 117
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 114
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 112
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 111
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 110
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 110
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 109
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 108
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 108
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 107
null 107
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 106
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 104
null 103
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 103
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 102
null 102
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 102
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 101
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 101
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 101
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 101
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 100
null 96
null 94
Non-invasive Prenatal Testing Using Fetal DNA 93
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 90
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 89
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 88
null 88
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 88
Alteration of microRNA biological activity with peptide nucleic acid 88
Gene therapy combined with HbF induction in beta-thalassemia 88
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 87
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 86
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 86
Development and molecular characterization of transgenic mice for beta-thalassemia 85
null 85
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 85
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 83
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 80
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 79
SPR-based identification of microRNAs 79
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 78
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 78
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 78
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of beta o 39 thalassemia mutation. 77
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 77
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 76
null 75
Targeting the miR-221/miR-222 cluster in cancer therapy 74
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 73
Gene therapy and fetal hemoglobin induction 73
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 73
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 73
Inhibition of micro RNA 221 biological activity with an anti-miR-221 peptide nucleic acid 72
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 72
PNA-mediated alteration of mRNA splicing 71
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 71
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 70
Cellular biosensors for the identification of fetal hemoglobin inducers 70
null 69
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 68
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 67
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 67
Detection of disorders in unamplified human genomic DNA 66
Peptide nucleic acids targeting miR-221 in human gliomas: uptake and modulation of miR-221 biological functions 65
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 64
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 64
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 62
Readthrough of the premature stop codon beta039-thalassemia 62
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 62
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 62
Production of a cellular model for the screening of inducers of fetal haemoglobin 61
null 61
Polyarginine peptide nucleic acids inhibit biological activity if microRNA 210 60
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 60
Totale 10.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.018
Totale 51.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.122 0 0 0 0 0 205 155 178 165 254 113 52
2020/20211.832 128 98 113 122 148 204 118 156 66 223 302 154
2021/20221.223 139 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20251.076 80 70 230 154 305 237 0 0 0 0 0 0
Totale 11.572